Atherosclerosis is the major process underlying cardiovascular disorders, and accounts for the majority of mortality and morbidity in the western world. This course will give more insights into the mechanism and ontogenesis of vessel narrowing (atherosclerosis). Special emphasis will be put on the contribution of inflammatory processes and lipid fluxes in the development of atherosclerotic lesions. Also the clinical end-points of atherosclerosis will be discussed.
The following subjects will be discussed:
Cholesterol metabolism and atherosclerotic lesion formation
Role of macrophages in atherosclerotic lesion formation
Role of inflammation in atherosclerotic lesion formation and progression
Therapeutic approaches for the stabilization of vulnerable atherosclerotic plaques
Mw. dr. Miranda van Eck
Students of Bio-Pharmaceutical Sciences.
Will be announced during the lectures.
Minimum of 5 students
The lecture series Biopharmaceutics (Atherosclerosis) will be given in 2010—211 from 29 November to 1 December. The examination is on 6 December.
For information, please contact mw. dr. Miranda van Eck (e-mail: email@example.com, tel. 527 6238).
Applications for the course can be send to the secretarial office of the Division of Biopharmaceutics (Sigrid Jansson; e-mail: firstname.lastname@example.org).